A patient presents with a solitary pulmonary nodule (SPN) on X-ray. The best investigation to come to diagnosis would be –
First, the core concept here is the evaluation of SPN. The main goal is to determine if it's benign or malignant. The standard approach usually starts with imaging. CT scan is more sensitive than X-ray for detecting and characterizing SPNs. It can show features like calcification, spiculation, and size, which help in differentiation.
The correct answer is likely CT scan. Why? Because CT provides detailed cross-sectional images, allowing better assessment of the nodule's characteristics. It's non-invasive and a first-step before considering more invasive tests like biopsy. PET is used later for staging or if there's a high suspicion of malignancy.
The wrong options would be sputum cytology, which is not reliable for SPN as most malignant nodules don't shed cells into sputum. Bronchoscopy might be used if there's a central lesion or if there's a high suspicion, but it's not the first step. MRI isn't typically used for lung lesions.
Clinical pearl: CT is the gold standard for evaluating SPN. It's important to remember the stepwise approach: start with CT, then consider PET or biopsy based on CT findings and other factors like patient history. Also, the size and features on CT guide the next steps—like if it's small and has benign features, follow-up might be appropriate.
**Core Concept**: The evaluation of a solitary pulmonary nodule (SPN) requires imaging modalities that provide high-resolution anatomical detail to assess characteristics like size, shape, calcification, and enhancement. Computed tomography (CT) is the cornerstone for initial characterization due to its superior sensitivity compared to plain radiography.
**Why the Correct Answer is Right**: A **contrast-enhanced CT scan** is the optimal first investigation for an SPN. It allows detailed assessment of nodule morphology (e.g., spiculation, lobulation, calcification patterns), vascular supply, and mediastinal lymphadenopathy. CT can distinguish benign features (e.g., calcified granulomas) from suspicious features (e.g., solid or part-solid nodules with irregular margins) and guides further management (e.g., biopsy or follow-up).
**Why Each Wrong Option is Incorrect**:
**Option A:** **Sputum cytology** has low sensitivity for SPN (8 mm, indeterminate CT features) to assess metabolic activity, not as an initial test.
**Option C:** **Bronchoscopy** is indicated only for central lesions or when CT-guided biopsy is contraindicated.
**Clinical Pearl / High-Yield Fact**: Always start with **contrast-enhanced CT** for SPN evaluation. Remember the "3 cm rule": nodules >3 cm are more likely malignant and require immediate biopsy. Follow-up imaging (e.g., low-dose CT at 6–12 months) is appropriate for small, low-risk nodules.
**Correct Answer: C. Contrast-enhanced CT scan**